Monopar Therapeutics Ownership & Insider Activity

Monopar Therapeutics (MNPR) institutional and insider ownership, recent insider transactions and ownership breakdown.

Insiders own 6.9% of shares outstanding. Institutional investors hold 22.8%. Over the past 90 days, insiders made 2 sales worth $807K.

Shares Outstanding

6.712M

Shares Float

4.586M

Insider Shares Owned

462.747K

Insider % Owned

6.9%

Institutional Shares Held

1.531M

Institutional % Held

22.8%

Ownership Breakdown

Net Insider Activity by Month

Purchases (90d)

Sales (90d)

$807K total

Net Activity

Net Selling

Net Value (90d)

-$807K

Monopar Therapeutics Insider Transactions (Last 6 Months)

Date	Insider	Title	Type	Shares	Price	Value
Nov 2, 2026	Raymond Anderson	DIRECTOR	SELL-OPTIONS	—	$49.17	$120K
Nov 2, 2026	Kim Tsuchimoto	DIRECTOR	SELL-OPTIONS	—	$46.48	$200K
Oct 1, 2026	CHRISTOPHER STARR	DIRECTOR	SELL-OPTIONS	—	$39.25	$659K
Sep 24, 2026	Chandler Robinson	CHIEF EXECUTIVE OFFICER	SELL-OPTIONS	—	$54.87	$1.9M
Aug 26, 2026	PATRICE RIOUX	—	SELL-OPTIONS	1.379K	$55.63	$104
Aug 26, 2026	Kim Tsuchimoto	DIRECTOR	SELL	4.090K	$111.39	$456K
Aug 25, 2026	Raymond Anderson	DIRECTOR	SELL	3.142K	$111.77	$351K